ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,286Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 224

$1.79M Total Retail Price of All Prescriptions

Rank: 4 out of 224

1,343 Patients Receiving at Least One Drug in Part D
78% Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

1% of this provider’s 1,343 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 48%.

Prescription Price

$125 was the average price of a prescription from this provider, compared to $168 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SYNTHROID 1,861 1,496 281 1 2
LEVOTHYROXINE SODIUM 1,451 1,067 274 2 1
GLIMEPIRIDE 693 588 134 3 7
BD ULTRA-FINE PEN NEEDLE 635 537 172 4 3
METFORMIN HCL 591 472 113 5 4
METHIMAZOLE 457 382 73 10 6 16
ATORVASTATIN CALCIUM 442 366 84 7 12
SIMVASTATIN 389 333 73 8 9
METFORMIN HCL ER 325 248 68 9 13
LANTUS 305 215 69 10 10
HUMALOG 302 199 94 11 8
LANTUS SOLOSTAR 275 224 72 12 5
LEVEMIR FLEXPEN 227 178 67 13 14
NOVOLOG 220 137 49 14 18
NOVOLOG FLEXPEN 219 177 63 15 6
JANUVIA 202 187 45 16 11
PRAVASTATIN SODIUM 187 144 35 17 23
INSULIN SYRINGE* 184 150 53 18 17
LOSARTAN POTASSIUM 165 154 33 19 25
HUMALOG MIX 75-25 160 128 33 20 27
INSULIN SYRINGE* 158 120 42 21 17
ZETIA 154 118 26 22 28
NATEGLINIDE 147 126 37 23 52
POTASSIUM CHLORIDE 136 111 23 24 55
NOVOLOG MIX 70-30 FLEXPEN 115 102 23 25 21
GABAPENTIN 113 86 20 26 37
CRESTOR 108 89 20 27 32
PIOGLITAZONE HCL 105 100* 20 R 28 19
JANUMET 102 84 23 29 33
LISINOPRIL 98 68 20 30 15
HUMULIN R 96 62 26 31 45
SENSIPAR 93 93 13 32 90
LEVEMIR 91 80 31 33 53
LEVOXYL 91 64 36 33 43
LOVAZA 89 47 17 35 40
NOVOLOG MIX 70-30 88 83* 18 36 83
INSULIN SYRINGE* 88 77 28 36 17
HYDROCHLOROTHIAZIDE 82 82 17 38 24
ANDROGEL 78 39 14 S3 39 51
NOVOLIN N 75 37 15 40 42
ARMOUR THYROID 73 38 16 R 41 99
TRADJENTA 67 42 20 42 31
CALCITRIOL 65 <11 <11 43 80
AMLODIPINE BESYLATE 64 59* 15 44 20
NOVOLIN 70-30 62 <11 <11 45 143
ZEMPLAR 60 55* 12 46 198
VICTOZA 3-PAK 60 32 18 46 30
OMEPRAZOLE 57 52* 12 48 38
HUMULIN N 56 44 18 49 29
DIOVAN 55 <11 <11 50 46
VITAMIN D2 54 54 13 51 107
RAMIPRIL 52 <11 <11 52 64
ACARBOSE 50 45* 12 53 72
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 13, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.